Aram Ghalali

450 total citations
23 papers, 339 citations indexed

About

Aram Ghalali is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Aram Ghalali has authored 23 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Aram Ghalali's work include Cancer, Lipids, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and RNA modifications and cancer (3 papers). Aram Ghalali is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and RNA modifications and cancer (3 papers). Aram Ghalali collaborates with scholars based in Sweden, United States and France. Aram Ghalali's co-authors include Ulla Stenius, Johan Högberg, Huiyuan Zheng, Fredrik Wiklund, Sandeep Kadekar, Michael S. Rogers, Pierre Lafolie, Javier Martín‐Renedo, Zhiwei Ye and Alan Fotoohi and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Aram Ghalali

23 papers receiving 334 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Aram Ghalali 157 70 56 53 49 23 339
Anne‐Kristin Fentz 186 1.2× 22 0.3× 25 0.4× 54 1.0× 32 0.7× 7 354
Youlin Kuang 195 1.2× 13 0.2× 139 2.5× 93 1.8× 116 2.4× 35 490
Carola E. Matus 114 0.7× 15 0.2× 145 2.6× 32 0.6× 70 1.4× 17 406
Yen-Ying Ma 179 1.1× 18 0.3× 20 0.4× 67 1.3× 100 2.0× 17 414
Tae Kusabiraki 159 1.0× 16 0.2× 74 1.3× 99 1.9× 12 0.2× 10 439
Zhengwen He 198 1.3× 13 0.2× 66 1.2× 97 1.8× 57 1.2× 29 370
Yuanxi Zhu 152 1.0× 11 0.2× 33 0.6× 92 1.7× 148 3.0× 8 364
Johanna Lundin 216 1.4× 25 0.4× 24 0.4× 21 0.4× 32 0.7× 20 397
Léa Delbos 207 1.3× 28 0.4× 82 1.5× 112 2.1× 65 1.3× 18 521
Xu Luo 169 1.1× 9 0.1× 40 0.7× 49 0.9× 35 0.7× 45 335

Countries citing papers authored by Aram Ghalali

Since Specialization
Citations

This map shows the geographic impact of Aram Ghalali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram Ghalali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram Ghalali more than expected).

Fields of papers citing papers by Aram Ghalali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aram Ghalali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram Ghalali. The network helps show where Aram Ghalali may publish in the future.

Co-authorship network of co-authors of Aram Ghalali

This figure shows the co-authorship network connecting the top 25 collaborators of Aram Ghalali. A scholar is included among the top collaborators of Aram Ghalali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aram Ghalali. Aram Ghalali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sesen, Julie, Sara Busatto, Caroline Stone, et al.. (2025). AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype. Journal of Experimental & Clinical Cancer Research. 44(1). 56–56. 1 indexed citations
2.
Sesen, Julie, Sana Nasim, Gregory G. Heuer, et al.. (2024). Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment. Frontiers in Neuroscience. 18. 1442110–1442110. 1 indexed citations
3.
Ghalali, Aram, Fahd Alhamdan, Swapna Upadhyay, et al.. (2024). Contrasting effects of intracellular and extracellular human PCSK9 on inflammation, lipid alteration and cell death. Communications Biology. 7(1). 985–985. 1 indexed citations
4.
Ghalali, Aram, et al.. (2023). Disease specific urinary biomarkers in the central nervous system. Scientific Reports. 13(1). 19244–19244. 3 indexed citations
5.
6.
Zhou, Kun, Jae Eun Cheong, Aram Ghalali, et al.. (2022). Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation. Molecular Cancer Therapeutics. 22(1). 25–36. 18 indexed citations
7.
Ghalali, Aram, Konrad H. Stopsack, James Mahmud Rice, et al.. (2022). AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer. Experimental & Molecular Medicine. 54(10). 1713–1726. 9 indexed citations
8.
Ghalali, Aram, Zhiwei Ye, Johan Högberg, & Ulla Stenius. (2020). PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells. Biomedicine & Pharmacotherapy. 127. 110112–110112. 9 indexed citations
9.
Fattori, Victor, Rafael González‐Cano, Daniëlle Peterse, et al.. (2020). Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugs. Pain. 161(6). 1321–1331. 36 indexed citations
10.
Paalme, Viiu, Mickaël Bourge, Chi‐Shiun Chiang, et al.. (2019). Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4. Frontiers in Immunology. 10. 2074–2074. 17 indexed citations
11.
Ghalali, Aram, James Mahmud Rice, Amanda E. Kusztos, et al.. (2019). Developing a novel FRET assay, targeting the binding between Antizyme-AZIN. Scientific Reports. 9(1). 4632–4632. 6 indexed citations
12.
Ghalali, Aram, Kerstin Sollerbrant, C. Theresa Vincent, et al.. (2018). CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial–Mesenchymal Plasticity in Breast Cancer. Cancer Research. 79(1). 47–60. 35 indexed citations
13.
Ghalali, Aram, Huiyuan Zheng, Johan Högberg, et al.. (2018). Toluene diisocyanate exposure and autotaxin–lysophosphatidic acid signalling. Toxicology and Applied Pharmacology. 355. 43–51. 7 indexed citations
14.
Bertacchini, Jessika, Laura Mediani, Francesca Beretti, et al.. (2018). Clusterin enhances AKT2‐mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit. Journal of Cellular Physiology. 234(7). 11188–11199. 21 indexed citations
15.
Ghalali, Aram, Javier Martín‐Renedo, Johan Högberg, & Ulla Stenius. (2017). Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors. Molecular Cancer Research. 15(6). 714–722. 19 indexed citations
16.
Ye, Zhiwei, Anna Axmon, Margareta Littorin, et al.. (2015). Toluene diisocyanate: Induction of the autotaxin-lysophosphatidic acid axis and its association with airways symptoms. Toxicology and Applied Pharmacology. 287(3). 222–231. 12 indexed citations
17.
Ghalali, Aram, Fredrik Wiklund, Huiyuan Zheng, Ulla Stenius, & Johan Högberg. (2014). Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells. Carcinogenesis. 35(7). 1547–1555. 55 indexed citations
18.
Ghalali, Aram, et al.. (2013). Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells. Biochemical and Biophysical Research Communications. 437(2). 280–286. 25 indexed citations
19.
Ye, Zhiwei, Aram Ghalali, Johan Högberg, & Ulla Stenius. (2011). Silencing p110β prevents rapid depletion of nuclear pAkt. Biochemical and Biophysical Research Communications. 415(4). 613–618. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Kristin Fentz Breakdown of academic impact, for papers by Youlin Kuang Breakdown of academic impact, for papers by Carola E. Matus Breakdown of academic impact, for papers by Yen-Ying Ma Breakdown of academic impact, for papers by Tae Kusabiraki Breakdown of academic impact, for papers by Zhengwen He Breakdown of academic impact, for papers by Yuanxi Zhu Breakdown of academic impact, for papers by Johanna Lundin Breakdown of academic impact, for papers by Léa Delbos Breakdown of academic impact, for papers by Xu Luo
Rankless by CCL
2026